The Detroit Office of the Food and Drug Administration (FDA) has reinspected Perrigo's Allegan facility as a follow-up to the warning letter the company has received in 30 April 2010.
Subscribe to our email newsletter
Perrigo is a global healthcare supplier engaged in developing, manufacturing and distributing OTC and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, active pharmaceutical ingredients (API) and pharmaceutical and medical diagnostic products.
The company’s primary markets and locations of manufacturing facilities are the US, Israel, Mexico and the UK.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.